Evidence map›Paper›PMID 39069809›Full record

ReviewCurrent medicinal chemistry2025

Antiprotozoal, Anthelmintic and Antivectorial Activities of Titanium Dioxide Nanoparticles.

Thainá Silva Bologna, Isabella de Oliveira Ferrato de Sousa, Jose Rodrigues do Carmo Neto, Thais Amanda de Lima Nunes, Beatriz Sodre Matos, Priscilla Elias Ferreira da Silva, Rhanoica Oliveira Guerra, Pablo Igor Ribeiro Franco, Juliana Reis Machado, Anielle Christine Almeida Silva and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Thainá Silva BolognaDepartment of Microbiology, Immunology and Parasitology, Institute of Biological and Natural Sciences of Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.
Isabella de Oliveira Ferrato de SousaDepartment of Microbiology, Immunology and Parasitology, Institute of Biological and Natural Sciences of Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.
Jose Rodrigues do Carmo NetoDepartment of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, GO, Brazil.
Thais Amanda de Lima NunesDepartment of Microbiology, Immunology and Parasitology, Institute of Biological and Natural Sciences of Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.
Beatriz Sodre MatosDepartment of Microbiology, Immunology and Parasitology, Institute of Biological and Natural Sciences of Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.
Priscilla Elias Ferreira da SilvaDepartment of Microbiology, Immunology and Parasitology, Institute of Biological and Natural Sciences of Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.
Rhanoica Oliveira GuerraDepartment of Cell Biology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
Pablo Igor Ribeiro FrancoDepartment of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, GO, Brazil.
Juliana Reis MachadoDepartment of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, GO, Brazil.
Anielle Christine Almeida SilvaLaboratory of New Nanostructured and Functional Materials, Physics Institute, Federal University of Alagoas, Maceió, Alagoas, Brazil.
Marcos Vinicius da SilvaDepartment of Microbiology, Immunology and Parasitology, Institute of Biological and Natural Sciences of Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.

Funding

Fundação de Amparo à Pesquisa do Estado Minas Gerais (FAPEMIG) RED-00198-23/RED-00224-23
6 · The paper itself

Abstract

Nanotechnology has been established as a promising alternative for treating a myriad of disease-causing microorganisms that pose threats to human health. The utilization of nanoparticles (NPs) emerges as a strategy to enhance the therapeutic arsenal against these diseases, especially given the tendency of many pathogens to develop resistance to conventional medications. Notably, titanium dioxide nanoparticles (TiO

Indexed as

AnthelminticsAntiprotozoal AgentsMetal NanoparticlesNanoparticlesTitaniumAnimalsHelminthsHumansAnthelminticsAntiprotozoal AgentsTitaniumtitanium dioxideanthelminticantiprotozoalbiosensorNanocompositenanoparticlesreptiles.titanium dioxide

Identifiers

PMID39069809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.